Quality of Life After Transcatheter Tricuspid Valve Replacement
Compared with OMT alone, treatment of patients with symptomatic and severe or greater TR with TTVR+OMT resulted in substantial improvement in patients' symptoms, function, and quality of life. These benefits were evident 30 days after TTVR, continued to increase through 6 months, and remained durable through 1 year. (TRISCEND II Pivotal Trial [Edwards EVOQUE Transcatheter Tricuspid Valve Replacement: Pivotal Clinical Investigation of Safety and Clinical Efficacy using a Novel Device]; NCT04482062).
Authors
- Sorin V. Pislaru (ORCID: https://orcid.org/0000-0002-5256-3150)
- Paul Grayburn (ORCID: https://orcid.org/0000-0002-9183-1373)
- Vinod H. Thourani (ORCID: https://orcid.org/0000-0002-9309-2623)
- Molly Szerlip (ORCID: https://orcid.org/0000-0002-4907-1825)
- Christiane Haeffele (ORCID: https://orcid.org/0000-0002-0176-6628)
- Susheel Kodali (ORCID: https://orcid.org/0000-0003-0517-2074)
- Akhil Narang (ORCID: https://orcid.org/0000-0001-9248-808X)
- Anna Sannino (ORCID: https://orcid.org/0000-0003-4275-8066)
- Brian Patrick O’Neill (ORCID: https://orcid.org/0000-0001-7456-6152)
- Suzanne V. Arnold (ORCID: https://orcid.org/0000-0003-3367-0302)
- Moody Makar (ORCID: https://orcid.org/0000-0003-4994-5796)
- Raj Makkar (ORCID: https://orcid.org/0000-0002-6613-519X)
- Mackram F. Eleid (ORCID: https://orcid.org/0000-0001-6082-5379)
- Rebecca Tung Hahn (ORCID: https://orcid.org/0000-0003-1342-9191)
- David J. Cohen (ORCID: https://orcid.org/0000-0003-1227-3252)
- Philipp Lurz (ORCID: https://orcid.org/0000-0002-5993-4487)
- Nishant K. Sekaran
- Firas Zahr (ORCID: https://orcid.org/0000-0001-8448-8880)
- Santiago A. Garcia (ORCID: https://orcid.org/0000-0002-1806-6783)
- Clayton Snyder
- Brian Whisenant (ORCID: https://orcid.org/0000-0002-2973-3369)
- Scott Chadderdon (ORCID: https://orcid.org/0000-0002-4985-4686)
- Terri Stewart-Dehner
- Yiran Zhang (ORCID: https://orcid.org/0000-0003-3105-5891)
- James Lee (ORCID: https://orcid.org/0000-0003-4030-1062)
- Rahul Sharma (ORCID: https://orcid.org/0000-0002-6854-750X)
- Pradeep Yadav (ORCID: https://orcid.org/0000-0003-1278-9136)
- Robert L. Smith (ORCID: https://orcid.org/0000-0002-3186-1001)
- Martin B Leon
- Charles J. Davidson
- Michael Mack
Institutions
- Northwestern University (US)
- Cedars-Sinai Medical Center (US)
- Mayo Clinic (US)
- Oregon Health & Science University (US)
- Johannes Gutenberg University Mainz (DE)
- Columbia University Irving Medical Center (US)
- Piedmont Atlanta Hospital (US)
- Henry Ford Hospital (US)
- Intermountain Medical Center (US)
- University Medical Center of the Johannes Gutenberg University Mainz (DE)
- Heart Hospital Baylor Plano (US)
- Christ Hospital (US)
- Saint Luke's Hospital (US)
- Cardiovascular Research Foundation (US)
- St. Francis Hospital (US)
- Stanford University (US)
Publication Details
- Journal
- Journal of the American College of Cardiology
- Published
- 2024-10-31
- DOI
- https://doi.org/10.1016/j.jacc.2024.10.067
- Citations
- 62
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 24.93
Funders
- Edwards Lifesciences